Does RITUXIMAB Cause Peripheral t-cell lymphoma unspecified? 32 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Peripheral t-cell lymphoma unspecified have been filed in association with RITUXIMAB (Rituxan). This represents 0.0% of all adverse event reports for RITUXIMAB.
32
Reports of Peripheral t-cell lymphoma unspecified with RITUXIMAB
0.0%
of all RITUXIMAB reports
11
Deaths
5
Hospitalizations
How Dangerous Is Peripheral t-cell lymphoma unspecified From RITUXIMAB?
Of the 32 reports, 11 (34.4%) resulted in death, 5 (15.6%) required hospitalization, and 1 (3.1%) were considered life-threatening.
Is Peripheral t-cell lymphoma unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Peripheral t-cell lymphoma unspecified?
ROMIDEPSIN (102)
BRENTUXIMAB VEDOTIN (89)
CYCLOPHOSPHAMIDE (65)
DOXORUBICIN (64)
PREDNISONE (53)
VINCRISTINE (38)
METHOTREXATE (37)
PREDNISOLONE (34)
ETOPOSIDE (26)
TACROLIMUS (22)
Which RITUXIMAB Alternatives Have Lower Peripheral t-cell lymphoma unspecified Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE